Mark Washa

Title: Mark Washa: Innovator in Microfluidic Technology

Introduction

Mark Washa is a prominent inventor based in Plymouth, MN (US). He has made significant contributions to the field of microfluidics, holding a total of 3 patents. His work focuses on enhancing the efficiency and functionality of microfluidic devices, which are crucial in various biological and chemical applications.

Latest Patents

Washa's latest patents include innovative designs that improve the performance of cytometric test cards. One of his notable inventions is the "Capillary groove for isobaric waste entry." This patent describes a multiple-layer cytometric test card that features a waste channel designed to receive biological waste. The card includes a first waste storage compartment with a capillary positioned along its vertical length, allowing for efficient waste management during testing.

Another significant patent is "Surface preparation for a microfluidic channel." This invention involves a microfluidic cartridge with a channel that has been treated to alter its surface characteristics. The treatment can include roughening or etching the surface to ensure even distribution of reagents across the channel, enhancing the overall performance of the microfluidic system.

Career Highlights

Mark Washa is currently employed at Honeywell International Inc., where he continues to develop innovative solutions in microfluidic technology. His work has been instrumental in advancing the capabilities of microfluidic devices, making them more effective for various applications in research and diagnostics.

Collaborations

Washa has collaborated with notable colleagues, including Ron Bardell and Tzu-Yu Wang. These partnerships have fostered a creative environment that encourages the development of cutting-edge technologies in the field.

Conclusion

Mark Washa's contributions to microfluidic technology through his patents and work at Honeywell International Inc. highlight his role as an influential inventor. His innovative designs continue to shape the future of biological testing and analysis.